Dr. Rand Paul’s Legislation to Lower Drug Prices Unanimously Advances Out of Committee
early stages of its analytical and safety assessment, there’s noscientific justification to delay access.” BACKGROUND Senator Paul … medicine and slows access rather than making safety and effectiveness determinations of medications. The agency’s increasing demands